DYNAVAX TECHNOLOGIES CORP (27)

Browse by Contract Category

Contracts

Kelly MacDonald Employment Letter (Filed With SEC on February 25, 2021)
Amendment No. 4 to Term Loan Agreement and Fee Letter, dated January 29, 2021, by and among Company, CRG Partners III L.P., CRG Partners III-Parallel Fund A L.P. and CRG Servicing... (Filed With SEC on February 25, 2021)
Agreement, dated January 29, 2021 between Company and Coalition for Epidemic Preparedness Innovations (Filed With SEC on February 25, 2021)
Supply Agreement, dated September 11, 2020, by and among the Company, Valneva Scotland Limited and Valneva Austria GmbH (Filed With SEC on November 5, 2020)
Sublease, by and between Dynavax Technologies Corporation and Zymergen Inc., dated July 12, 2019 (Filed With SEC on November 7, 2019)
Description of Capital Stock (Filed With SEC on February 25, 2021)
Dynavax Technologies Corporation 2021 Inducement Award Plan, Form of Stock Option Grant Notice, Option Agreement, Form of Restricted Stock Grant Notice and Restricted Stock Unit... (Filed With SEC on January 12, 2021)
Amendment No. 3 to Term Loan Agreement and Fee Letter, dated November 2, 2020, by and among Company, CRG Partners III L.P., CRG Partners III-Parallel Fund A L.P. and CRG Servicing... (Filed With SEC on November 5, 2020)
Amended and Restated Management Continuity and Severance Agreement, dated September 22, 2020, between Michael S. Ostrach and the Company (Filed With SEC on November 5, 2020)
Sales Agreement, dated August 6, 2020, between the Company and Cowen and Company, LLC (Filed With SEC on August 6, 2020)
Amended and Restated 2004 Non-Employee Director Equity Program and Amended and Restated 2005 Non-Employee Director Cash Compensation Program, as amended (Filed With SEC on August 6, 2020)
Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 6, 2020)
Underwriting Agreement, dated May 21, 2020, by and among Dynavax Technologies Corporation, Cowen and Company, LLC, Evercore Group L.L.C. and William Blair & Company, L.L.C., as... (Filed With SEC on May 22, 2020)
Dynavax Technologies Corporation U.S. Annual Bonus Plan (Filed With SEC on March 11, 2020)
President and Chief Operating Officer Letter, dated December 13, 2019, between the Company and David Novak (Filed With SEC on March 11, 2020)
Chief Executive Officer Letter, dated December 13, 2019, between the Company and Ryan Spencer (Filed With SEC on March 11, 2020)
Description of Capital Stock (Filed With SEC on March 11, 2020)
Form of Series B Preferred Stock Certificate (Filed With SEC on November 7, 2019)
Amendment No. 2 to Term Loan Agreement and Fee Letter, by and among Dynavax Technologies Corporation, CRG Partners III L.P., CRG Partners IIIParallel Fund A L.P. and CRG Servicing... (Filed With SEC on November 7, 2019)
Sublease, by and between Dynavax Technologies Corporation and MedAmerica, Inc. (d/b/a Vituity), dated July 2, 2019 (Filed With SEC on November 7, 2019)
Form of Indemnification Agreement (Filed With SEC on November 7, 2019)
Form of Warrant to Purchase Common Stock (Filed With SEC on August 8, 2019)
Underwriting Agreement, dated April 7, 2019, by and among Dynavax Technologies Corporation, Cowen and Company, LLC and William Blair & Company, L.L.C., as representatives of the... (Filed With SEC on August 8, 2019)
Form of Amended and Restated Management Continuity and Severance Agreement between the Company and certain of its executive officers (Filed With SEC on August 7, 2019)
Co-President Officer Letter, dated May 30, 2019, between the Company and Ryan Spencer (Filed With SEC on August 7, 2019)
Co-President Officer Letter, dated May 30, 2019, between the Company and David Novack (Filed With SEC on August 7, 2019)
Amended and Restated 2018 Equity Incentive Plan (Filed With SEC on August 7, 2019)